M16-006
ClinicalTrials.gov NCT03105102
Research payments
$6,028,596
Through program year 2020, $6,028,596 in research payments was reported against M16-006, across 902 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03105102
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $2,895,211 | 462 |
| 2019 | Research | $3,133,384 | 440 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kwabena Ayesu Orlando, FL Named on 48 payments
- Henry Levine Orlando, FL Named on 29 payments
- Deborah Flomenhoft Lexington, KY Named on 27 payments
- Paul Hellstern Crystal River, FL Named on 26 payments
- Syed Mumtaz Kissimmee, FL Named on 23 payments
- Harry Ojeas Houston, TX Named on 23 payments
- George Duvall Vero Beach, FL Named on 22 payments
- Sara Horst Nashville, TN Named on 20 payments
- Joe Pouzar Houston, TX Named on 19 payments
- Jonathon Chapman Baton Rouge, LA Named on 18 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.